Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-02-11

Clinical Trial Update: Clinical Post Market Clinical Follow-up (PMCF) on Peripheral Arteries Treated With SeQuent® Please Over The Wire (OTW)

View source ↗

Summary

This is an update on a post-market clinical follow-up study evaluating the SeQuent Please Over The Wire paclitaxel-coated balloon for treating peripheral arteri…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SeQuent Please OTW (paclitaxel-coated balloon)

Snippet

Sponsor: B. Braun Melsungen AG | Conditions: Peripheral Arterial Occlusive Disease | Status: ACTIVE_NOT_RECRUITING